MedTrace Logo

Is the Concentration of Anti-Muellerian Hormon (AMH) Depending on the Menstrual Cycle?

NCT03398603 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-01-28

No results posted yet for this study

Summary

The developement of a new, stable measurement of the Antimuellerian Hormon (AMH) together with Roche Diagnostics International (Rotkreuz, CH) shall enable an automized and timely measurement of AMH values in blood samples.

Conditions

  • Ovarian Failure

Interventions

PROCEDURE

blood sample and ultrasound

When included in the study blood samples and ultrasound are taken every second day of the first and third menstrual cycle after inclusion.

Sponsors & Collaborators

  • Roche Diagnostic Ltd.

    collaborator INDUSTRY

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Christian De Geyter, Prof. · USB

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2018-08-31
Completion
2019-10-13

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03398603 on ClinicalTrials.gov